MARKHAM, Ontario--(BUSINESS WIRE)--Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu™ micro-ultrasound platform to MRI ...
Global map of countries (n = 17) and the number of scanners (n = 64) that took part in phase II of the Global Variation in Magnetic Resonance Imaging Qualtiy of the Prostate (GLIMPSE) study. UK = ...
In patients with biochemical failure after prostatectomy, about two thirds showed detectable local disease at restaging. Multiparametric MRI alone detected local lesions in over one third of patients ...
A new survey of UK radiologists finds that 100% of NHS trusts have now used pre-biopsy MRI, although variations persist in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback